Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
7 Results for "
gastric fat
" in MedChemExpress (MCE) Product Catalog:
Products (7)
7 Results for "gastric fat" in MCE Product Catalog:
2
2 Cited Publications
Synonyms: Salicylsalicylic acid; Disalicylic acid
Target:
Research Areas:
Salsalate is a potent antirheumatic drug with oral activity that reduces irritation during gastric absorption and avoids direct inhibition of cyclooxygenase. Salsalate not only has significant anti-inflammatory effects, but also reduces blood sugar levels, improves insulin resistance, and reduces the expression of cytokines. Salsalate can protect mice from metabolic disorders caused by high-fat diet and effectively improve the symptoms of type 2 diabetes, atherosclerosis and non-alcoholic steatohepatitis [2 ] .
Target:
Research Areas:
Bisbentiamine is a lipophilic thiamine prodrug with pH-dependent solubility. The bioavailability of Bisbentiamine is regulated by diet type, administration time, gastric acidity, and formulation .
Cat. No.: HY-19656
CAS No.: 262376-75-0
Target:
Research Areas:
HMR1426 is an orally active, potent gastric emptying inhibitor. HMR1426 reduces food intake and the rate of gastric emptying, decreases body weight and fat mass and shows an anorectic potential in rats. HMR1426 has the potential for obesity research .
Cat. No.: HY-P3578
CAS No.: 134875-67-5
Target:
Research Areas:
Cat. No.: HY-D3068
CAS No.: 3077446-86-4
Target:
Research Areas:
LDs-BCA is a BF2-chelated AIE fluorescent probe with a positive solvatochromic effect, which can specifically target intracellular lipid droplets (Ex/Em = 565/620-730 nm). LDs-BCA monitors the dynamic changes in the morphology, size and quantity of intracellular lipid droplets under oleic acid induction and starvation stress. LDs-BCA, after intraperitoneal injection, accumulates in the gastric fat of living obese mice, allowing continuous monitoring via its fluorescent signal. LDs-BCA is applicable to studies related to intracellular lipid droplet polarity imaging and in vivo gastric fat visualization .
Cat. No.: HY-186096
Target:
Research Areas:
LP-856866 is an orally active ACSL5 inhibitor, with IC50 values of 8 nM and 4 nM against mouse and human ACSL5, respectively, and IC50 values of 6 nM and 17 nM against mouse and human ACSL1, respectively. LP-856866 induces delayed gastric emptying, promotes GLP-1 release, reduces food intake, decreases body weight and body fat mass, preserves lean body mass, improves glucose homeostasis, enhances insulin sensitivity, reduces hepatic lipid accumulation, and lowers serum triglyceride and total cholesterol levels. LP-856866 is applicable to research on diet-induced obesity .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
